^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BA1202
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Luye Group
Drug class:
CD3 agonist, CEA inhibitor
Related drugs:
Phase 1
Shandong Boan Biotechnology Co., Ltd
Recruiting
Last update posted :
04/25/2024
Initiation :
08/16/2023
Primary completion :
02/01/2025
Completion :
12/01/2026
CEACAM5
|
BA1202
Share
